You are here

Home / Resources / Key Material
Export 95 results:
Filters: First Letter Of Last Name is G  [Clear All Filters]
A
Valdramidis, V. Panagiotis, Bernaerts K., Van Impe J. Frans, & Geeraerd A. Helena (2005).  An alternative approach to non-log-linear thermal microbial inactivation: modelling the number of log cycles reduction with respect to temperature. Food Technology and Biotechnology. 43, 321–327.
Shepard, C.. W., Soriano-Gabarro M.., Zell E.. R., Hayslett J.., Lukacs S.., Goldstein S.., et al. (2002).  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging infectious diseases. 8, 10.
Tribble, D. R., Baqar S., Scott D. A., Oplinger M. L., Trespalacios F., Rollins D., et al. (2010).  Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78, 4.
McQuaig, S., Griffith J., & Harwood V. J. (2012).  Association of fecal indicator bacteria with human viruses and microbial source tracking markers at coastal beaches impacted by nonpoint source pollution. Applied and environmental microbiology. 78, 6423–6432.
B
Gurian, P.. L., Small M.. J., Lockwood J.. R., & Schervish M.. J. (2001).  Benefit-cost estimation for alternative drinking water maximum contaminant levels. Water Resources Research. 37, 8.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J. A., Stephens D. S., Ashford D. A., Omenaca C., Topiel M. S., Galbraith M., et al. (2001).  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.. Emerging infectious diseases. 7, 933.
C
Mafart, P., Couvert O., Gaillard S., & Leguérinel I. (2002).  On calculating sterility in thermal preservation methods: application of the Weibull frequency distribution model. International journal of food microbiology. 72, 107–113.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Hamory, B.. H., Couch R.. B., G., Jr D. R., Black S.. H., & Knight V.. (1972).  Characterization of the infectious unit for man of two respiratory viruses. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.).. 139, 3.
Golnazarian, C. A., Donnelly C. W., Pintauro S. J., & Howard D. B. (Submitted).  Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. Journal of food protection. 52, 10.
Connolly, G.. M., Dryden M.. S., Shanson D.. C., & Gazzard B.. G. (1988).  Cryptosporidial diarrhoea in AIDS and its treatment.
593-597
Painter, J. E., Hlavsa M. C., Collier S. A., Xiao L., Yoder J. S., & Gargano J. W. (2015).  Cryptosporidiosis surveillance–United States, 2011-2012; Giardiasis surveillance–United States, 2011-2012. Morbidity and Mortality Weekly Report: Surveillance Summaries. 64(3), 
Betancourt, W. Q., Duarte D. C., Vásquez R. C., & Gurian P. L. (2014).  Cryptosporidium and Giardia in tropical recreational marine waters contaminated with domestic sewage: Estimation of bathing-associated disease risks. Marine pollution bulletin. 85, 268–273.
D
Gouvea, V.. S., Alencar A.. A., Barth O.. M., de C. L., Fialho A.. M., Araújo H.. P., et al. (1986).  Diarrhoea in Mice Infected with a Human Rotavirus. Journal of General Virology. 67, 3.
Collier, SA., Stockman LJ., Hicks LA., Garrison LE., Zhou FJ., & Beach MJ. (2012).  Direct healthcare costs of selected diseases primarily or partially transmitted by water. Epidemiology & Infection. 140, 2003–2013.
Friedler, E., Yardeni A., Gilboa Y., & Alfiya Y. (2011).  Disinfection of greywater effluent and regrowth potential of selected bacteria. Water Science and Technology. 63, 931–940.
Chen, L., Geys H., Cawthraw S., Havelaar A., & Teunis P. (2006).  Dose response for infectivity of several strains of Campylobacter jejuni in chickens. Risk Analysis. 26, 1613–1621.
Chen, L.., Geys H.., Cawthraw S.., Havelaar A.., & Teunis P.. (2006).  Dose response for infectivity of several strains of ''Campylobacter jejuni'' in chickens. Risk Analysis. 1613-1621.
Chen, L.., Geys H.., Cawthraw S.., Havelaar A.., & Teunis P.. (2006).  Dose response for infectivity of several strains of Campylobacter jejuni in chickens. Risk Analysis: An Official Publication of the Society for Risk Analysis. 26, 1613-1621.